Mesothelioma Study Explores New Treatment When Chemotherapy Fails
Mesothelioma Study Explores New Treatment When Chemotherapy Fails A clinical trial exploring novel immunotherapy/antiangiogenic combination serve as an effective treatment pleural mesothelioma. indications the four-center, well-known immunotherapy drug, drug that blocks the blood vessels needed new tumor growth. The and Drug Administration approved drugs the treatment other cancers,” medical oncologist Alberto Chiappori, told Mesothelioma Center at Asbestos. “But we have seen any reason be encouraged. There everything assume we expect positive Mesothelioma Study Explores outcome. Cancer researchers at Baylor College of Medicine have launched a new mesothelioma immunotherapy trial. The trial combines the cancer drug Opdivo (nivolumab) with injections of a modified virus called MTG201. Baylor scientists are hoping to recruit 12 pleural mesothelioma patients whose cancer has come back after chemotherapy. The treatment combination appeared to work well in mice with mesothe...